Volume : 10, Issue : 12, December – 2023
Title:
AN OVERVIEW OF INFECTION PREVENTION AND CONTROL OF CANDIDA AURIS
Authors :
Wesaam Mohammad Ghafuri , Asmaa Ali Sayis , Arwa Hussain Dawaje, Tahani M Alsaedi , Nuha Fuaad Maddah , Adnan Suliman Alsaedi ,Hanan Hameed Almalki , Hussain Jaber Ageeli , Sultan Moraya ALqahtani
Abstract :
The rising prevalence of immunocompromised patients and the high incidence of candidiasis have made Candida auris a significant issue in critical care medicine, as it is the most common cause of fungal infections. The Infection Prevention and Control working group of the International Society of Antimicrobial Chemotherapy convened a meeting of experts in infection prevention and mycology to assess guidelines for healthcare workers regarding infection prevention and control measures for C. auris in inpatient healthcare facilities. The predominant interventions encompassed screening, implementation of standard precautions, thorough cleaning and disinfection, transportation of patients within the hospital, management of outbreaks, decolonization procedures, and provision of medication.
Cite This Article:
Please cite this article in press Asmaa Ali Sayis et al., An Overview Of Infection Prevention And Control Of Candida Auris, Indo Am. J. P. Sci, 2023; 10 (12).
Number of Downloads : 10
References:
1. de Cassia Orlandi Sardi J, Silva DR, Soares Mendes-Giannini MJ, Rosalen PL. Candida auris: epidemiology, risk factors, virulence, resistance, and therapeutic options. Microb Pathog 2018;125:116–121.
2. Osei Sekyere J. Candida auris: a systematic review and meta-analysis of cur- rent updates on an emerging multidrug-resistant pathogen. Microbiol Open 2018;7(4):e00578.
3. Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treat- ment of infections by Candida auris. J Intensive Care 2018;6:69.
4. Forsberg K, Woodworth K, Walters M, et al. Candida auris: the recent emergence of a multidrug-resistant fungal pathogen. Med Mycol 2019; 57:1–12.
5. Dudiuk C, Berrio I, Leonardelli F, et al. Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris. J Antimicrob Chemother 2019;74:2295–2302.
6. Sabino R., Veríssimo C., Pereira Á.A., Antunes F. Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? Microorganisms. 2020;8:181.
7. Du H., Bing J., Hu T., Ennis C.L., Nobile C.J., Huang G. Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020;16:e1008921.
8. Theodoropoulos N.M., Bolstorff B., Bozorgzadeh A., Brandeburg C., Cumming M., Daly J.S., Ellison R.T., 3rd, Forsberg K., Gade L., Gibson L., et al. Candida auris outbreak involving liver transplant recipients in a surgical intensive care unit. Am. J. Transpl. 2020;20:3673–3679.
9. Logan C., Martin-Loeches I., Bicanic T. Invasive candidiasis in critical care: Challenges and future directions. Intensive Care Med. 2020;46:2001–2014.
10. Abdalhamid B, Almaghrabi R, Althawadi S, Omrani A. First report of Candida auris infections from Saudi Arabia. J Infect Public Health 2018;11:598–599.
11. Elsawy A, Alquthami K, Alkhutani N, Marwan D, Abbas A. The second con- firmed case of Candida auris from Saudi Arabia. J Infect Public Health 2019;12:907–908.
12. Fernandes L., Ribeiro R., Henriques M., Rodrigues M.E. Candida auris, a singular emergent pathogenic yeast: Its resistance and new therapeutic alternatives. Eur. J. Clin. Microbiol. Infect. Dis. 2022;41:1371–1385.
13. Mohsin J., Weerakoon S., Ahmed S., Puts Y., Al Balushi Z., Meis J.F., Al-Hatmi A.M.S. A Cluster of Candida auris Blood Stream Infections in a Tertiary Care Hospital in Oman from 2016 to 2019. Antibiotics. 2020;9:638.
14. Casadevall A., Kontoyiannis D.P., Robert V. Environmental Candida auris and the Global Warming Emergence Hypothesis. mBio. 2021;12:e00360-21.
15. Watkins R.R., Gowen R., Lionakis M.S., Ghannoum M. Update on the Pathogenesis, Virulence, and Treatment of Candida auris. Pathog. Immun. 2022;7:46–65.
16. Escandón P. Novel Environmental Niches for Candida auris: Isolation from a Coastal Habitat in Colombia. J. Fungi. 2022;8:748.
17. Satoh K., Makimura K., Hasumi Y., Nishiyama Y., Uchida K., Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol. Immunol. 2009;53:41–44.
18. Lockhart S.R., Etienne K.A., Vallabhanni S., Farooqi J., Chowdhary A., Govender N.P., Colombo A.L., Calvo B., Cuomo C.A., Desjardins C.A., et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin. Infect. Dis. 2017;64:134–140.
19. Chow N.A., de Groot T., Badali H., Abastabar M., Chiller T.M., Meis J.F. Potential Fifth Clade of Candida auris, Iran, 2018. Emerg. Infect. Dis. 2019;25:1780–1781.
20. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 2009;48:e57–61.
21. Chowdhary A, Voss A, Meis JF. Multidrug-resistant Candida auris: ‘new kid on the block’ in hospital-associated infections? J Hosp Infect 2016;94:209–12.
22. Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis 2014;33:919–26.
23. Ledwoch K, Maillard JY. Candida auris Dry Surface Biofilm (DSB) for Disinfectant Efficacy Testing. Materials (Basel) 2018;12.
24. Abdolrasouli A, Armstrong-James D, Ryan L, Schelenz S. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris. Mycoses 2017;60:758–63.
25. Mathur P, Singh PK, Malhotra R, Walia K, Chowdhary A. Five-year profile of candidemia at an Indian Trauma Center: high rates of Candida auris blood stream infections.Mycoses 2018;61:674–80.
26. Adams E, Quinn M, Tsay S, Poirot E, Chaturvedi S, Southwick K, et al. Can- dida auris in Healthcare Facilities, New York, USA, 2013-2017. Emerg Infect Dis 2018;24:1816–24.
27. Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, et al. First three re- ported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol 2011;49:3139–42.
28. Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investi- gation of the First Seven Reported Cases of Candida auris, a Globally Emerg- ing Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016. MMWR 2017;65:1234–7.
29. Cadnum JL, Shaikh AA, Piedrahita CT, Jencson AL, Larkin EL, Ghannoum MA, et al. Relative Resistance of the Emerging Fungal Pathogen Candida auris and Other Candida Species to Killing by Ultraviolet Light. Infect Control Hosp Epi- demiol 2018;39:94–6.
30. Rutala WA, Kanamori H, Gergen MF, Sickbert-Bennett EE, Weber DJ. Suscepti- bility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities. Infect Control Hosp Epidemiol 2019;40:380–2.
31. Cadnum JL, Shaikh AA, Piedrahita CT, Sankar T, Jencson AL, Larkin EL, et al. Ef- fectiveness of Disinfectants Against Candida auris and Other Candida Species. Infect Control Hosp Epidemiol 2017;38:1240–3.